<DOC>
	<DOCNO>NCT02365285</DOCNO>
	<brief_summary>The investigator test hypothesis acute central acetylcholinesterase inhibition restore PNS activity reduce oxidation AAW compare white .</brief_summary>
	<brief_title>Racial Differences Vagal Control Glucose Homeostasis</brief_title>
	<detailed_description>Obesity great detrimental impact health African American woman ( AAW ) racial gender group . Nearly 80 % AAW overweight obese . Reduced insulin sensitivity prevalent among AAW compare white woman men race . This condition put AAW increase risk development type 2 diabetes mellitus . The exact mechanism underlie pathophysiological difference remain unknown . The investigator find obese AAW decrease parasympathetic nerve ( PNS ) activity compare white recent study animal model show PNS confers protection oxidative stress . In AA cohort , PNS activity directly correlate insulin sensitivity obese AAW even control difference age , blood pressure visceral adiposity . Equally important , investigator also show decrease insulin sensitivity associate increase oxidative stress measure plasma level F2-isoprostanes . Taken together finding lead u hypothesize decreased PNS activity obese AAW compare white woman deleterious effect oxidative stress insulin sensitivity.The investigator test hypothesis acute central acetylcholinesterase inhibition restore PNS activity reduce oxidation AAW compare white .</detailed_description>
	<mesh_term>Galantamine</mesh_term>
	<criteria>Female African American white ( race selfdefined , subject report parent race include ) 1860 year old BMI 3045 Kg/m2 Not pregnant breastfeed Pregnant breastfeeding Diabetes diagnosis ( defined American Diabetes Association ( ADA ) criterion ) 38 Cardiovascular disease myocardial infarction within 6 month prior enrollment , presence angina pectoris , significant arrhythmia , congestive heart failure ( LV hypertrophy acceptable ) , deep vein thrombosis , pulmonary embolism , mitral valve stenosis , aortic stenosis , hypertrophic cardiomyopathy . Arrhythmia ( first , second , thirddegree atrioventricular ( AV ) block ) Significant weight change &gt; 5 % past 3 month Impaired hepatic function ( AST and/or Alanine transaminase ( ALT ) &gt; one one half time ( 1.5X ) upper limit normal range ) Impaired renal function ( eGFR &lt; 60ml/min ) Users strong inhibitor Cytochrome P450 3A4 ( CYP3A4 ) cytochrome P450 , family 2 , subfamily D , polypeptide 6 ( CYP2D6 ) Users acetylcholinesterase inhibitor pyridostigmine bethanechol History alcohol drug abuse Mental condition render subject unable understand nature , scope , possible consequence study Inability comply protocol , e.g. , uncooperative attitude , inability return followup visit , unlikelihood completing study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>